Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In partnership with the Wellcome Innovations Flagship Programme, MORU launched its Critical Care Asia Network project with its first investigators’ meeting on 19-20 Aug in Bangkok. The project will establish an Asian ICU network across 42 ICUs in nine countries and implement a setting-adapted electronic registry.

Using the registry as well as qualitative methods, this project will evaluate the quality of critical care within the network, which will then lead into locally-led quality improvement interventions aiming to improve ICU performance and patient outcomes.

Building on methodology developed by our partners in Sri Lanka, Pakistan and India, the electronic registry will provide epidemiological data and map processes of care, involving caregivers and patients and family members. This will be complemented by qualitative evaluations of care processes, with the aim to empower healthcare teams to identify targets for improvement. Quality improvement interventions and research will be driven by priorities set by the network collaborators. The project works in close collaboration with the Flagship project lead by the OUCRU team on developing new low-cost technologies for ICUs in low/middle income countries. The network will also provide a platform for clinical trials planned for the next phase of the project. Follow the project on Twitter, as well via Rashan’s Twitter handle.

Above photo, collaborators at the Bangkok meeting (front row, from left): Dr Khamsay Detleuxay, Dr Nguyen Thien Binh, Dr Lakshmi Rangananthan, Dr Sophie Yacoub, Dr Rebecca Inglis, Dr Gyan Kayastha, Dr Mavuto Mukaka, Dr Victoria Adewole, Dr Louise Thwaites; (middle row): Dr Nguyen Thanh Nguyen , Dr Dong Phu Khiem, Dilanthi Gamage, Dr Lam Minh Yen, Dr Kathleen Thomas, Dr Bui Thi Hanh Duyen,  Dr Duong Bich Thuy, Dr Madiha Hashmi, Prof Ramani Moonesinghe, Dr Rozina Sultana, Abi Beane, Dr Syed Muhammad Muneeb Ali; (back row): Dr Arshad Taqi, Dr Dinh Minh Duc, Dr Rashan Haniffa, Dr Will Schilling, Ishara Udayanga, Prof. Marcus Schultz, Dr Swagata Tripathy, Prof Arjen M. Dondorp, Dr Muhammad Hayat, Dr Diptesh Aryal. Absent: Dr Steve Harris, Dr Bharath Kumar, Dr Jorge Salluh, Dr Meghan Lever, Dr Chris Pell, Dr Tamilarasu Kadhiravan, Dr Chairat Permpikul, Dr Ratapum Champunot, Dr Gentle Shrestha, Dr Rajyabardhan Pattnaik, Prof Guy Thwaites and Prof Yoell Lubell.

­- With thanks to Abi Beane for text and Jan Ariyalikit for photos

Similar stories

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

MORU Bangkok Publication Research

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.

Susie Dunachie awarded flagship NIHR career development award

Awards & Appointments MORU Bangkok

Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand. Congratulations!

The COVID-19 vaccine: do we know enough to end the pandemic?

MORU Bangkok Research

Blog by Rima Shretta. Preliminary efficacy results from three vaccine candidates currently in Phase 3 trials have shown an efficacy of more than 90% against the development of symptomatic COVID-19. While these results are promising, all vaccines are in relatively early stages of testing. A comprehensive and transparent roadmap is urgently needed, to determine how limited doses of the first vaccines to be licensed will be distributed, together with which groups will initially be prioritized.

New study on the risk of Plasmodium vivax parasitaemia after Plasmodium falciparum malaria

MORU Bangkok Publication Research

A new study quantifying the high risk of Plasmodium vivax parasitaemia after treatment of Plasmodium falciparum malaria aims to identify populations in which a policy of universal radical cure, combining artemisinin-based combination therapy with a hypnozoitocidal antimalarial drug, would be most beneficial.

Applicability of COVID-19 vaccine trial results to low-and-middle-income countries

COVID-19 MORU Bangkok

In the next few months, the first Phase 3 COVID-19 vaccine trials – the majority of them in upper-middle or high-income countries and in specific target populations like young adults – will report their results. How relevant will their study results be for low-resource settings?

Congratulations new NDM professors

Awards & Appointments LOMWRU MORU Bangkok

The University of Oxford has awarded CTMGH two new Professors. Elisabeth Ashley - UK-trained physician who specialises in infectious diseases and medical microbiology & virology, and Director of the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) in Lao PDR since 2019, Liz is conferred the title of Professor of Tropical Medicine. Stuart Blacksell - Senior Research Scientist based at the Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Thailand, Stuart is conferred the title of Professor of Tropical Microbiology.